SG11202100766TA - New attenuated virus strain and use thereof as a vaccine - Google Patents
New attenuated virus strain and use thereof as a vaccineInfo
- Publication number
- SG11202100766TA SG11202100766TA SG11202100766TA SG11202100766TA SG11202100766TA SG 11202100766T A SG11202100766T A SG 11202100766TA SG 11202100766T A SG11202100766T A SG 11202100766TA SG 11202100766T A SG11202100766T A SG 11202100766TA SG 11202100766T A SG11202100766T A SG 11202100766TA
- Authority
- SG
- Singapore
- Prior art keywords
- vaccine
- virus strain
- attenuated virus
- new attenuated
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18361—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18561—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1856801A FR3084079A1 (fr) | 2018-07-23 | 2018-07-23 | Nouvelle souche virale attenuee et son utilisation en tant que vaccin |
| FR1902934A FR3084086B1 (fr) | 2018-07-23 | 2019-03-21 | Nouvelle souche virale atténuée et son utilisation en tant que vaccin |
| PCT/FR2019/051759 WO2020021180A1 (fr) | 2018-07-23 | 2019-07-12 | Nouvelle souche virale attenuee et son utilisation en tant que vaccin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202100766TA true SG11202100766TA (en) | 2021-03-30 |
Family
ID=65243690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202100766TA SG11202100766TA (en) | 2018-07-23 | 2019-07-12 | New attenuated virus strain and use thereof as a vaccine |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11504424B2 (es) |
| EP (1) | EP3826671B1 (es) |
| JP (1) | JP2021531783A (es) |
| KR (1) | KR20210049099A (es) |
| CN (1) | CN112888456A (es) |
| AU (1) | AU2019311320A1 (es) |
| BR (1) | BR112021001146A2 (es) |
| CA (1) | CA3107080A1 (es) |
| FR (2) | FR3084079A1 (es) |
| IL (1) | IL280335B2 (es) |
| MX (1) | MX2021000949A (es) |
| SG (1) | SG11202100766TA (es) |
| WO (1) | WO2020021180A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3089789B1 (fr) * | 2018-12-14 | 2022-05-27 | Univ Claude Bernard Lyon | Production de vaccins viraux sur une lignee cellulaire aviaire |
| WO2023166079A1 (en) | 2022-03-02 | 2023-09-07 | Vaxxel | Vaccine composition against two respiratory viruses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1485468A4 (en) * | 2002-02-21 | 2007-01-03 | Medimmune Vaccines Inc | EXPRESSION SYSTEMS OF RECOMBINANT PARAINFLUENZA VIRUSES AND VACCINES COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM METAPNEUMOVIRUS |
| DE10221836A1 (de) * | 2002-05-16 | 2003-12-04 | Lohmann Animal Health Gmbh | Attenuierung von Metapneumovirus |
| EP1603939A2 (en) * | 2003-02-28 | 2005-12-14 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Recombinant human metapneumovirus and its use |
| WO2007038862A1 (en) * | 2005-10-03 | 2007-04-12 | Seneca College Of Applied Arts & Technology | Nucleic acid immunological composition for human metapneumovirus |
| EP2636413A1 (en) * | 2012-03-09 | 2013-09-11 | Ecole Normale Superieure De Lyon | Chimeric virus-like particles (VLP) containing functional hMPV proteins |
-
2018
- 2018-07-23 FR FR1856801A patent/FR3084079A1/fr active Pending
-
2019
- 2019-03-21 FR FR1902934A patent/FR3084086B1/fr active Active
- 2019-07-12 EP EP19758792.6A patent/EP3826671B1/fr active Active
- 2019-07-12 US US17/262,263 patent/US11504424B2/en active Active
- 2019-07-12 JP JP2021503802A patent/JP2021531783A/ja active Pending
- 2019-07-12 WO PCT/FR2019/051759 patent/WO2020021180A1/fr unknown
- 2019-07-12 KR KR1020217004934A patent/KR20210049099A/ko not_active Application Discontinuation
- 2019-07-12 AU AU2019311320A patent/AU2019311320A1/en active Pending
- 2019-07-12 MX MX2021000949A patent/MX2021000949A/es unknown
- 2019-07-12 IL IL280335A patent/IL280335B2/en unknown
- 2019-07-12 CA CA3107080A patent/CA3107080A1/fr active Pending
- 2019-07-12 BR BR112021001146-3A patent/BR112021001146A2/pt unknown
- 2019-07-12 CN CN201980062098.4A patent/CN112888456A/zh active Pending
- 2019-07-12 SG SG11202100766TA patent/SG11202100766TA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL280335B2 (en) | 2024-10-01 |
| FR3084079A1 (fr) | 2020-01-24 |
| MX2021000949A (es) | 2021-06-23 |
| IL280335B1 (en) | 2024-06-01 |
| KR20210049099A (ko) | 2021-05-04 |
| JP2021531783A (ja) | 2021-11-25 |
| WO2020021180A1 (fr) | 2020-01-30 |
| EP3826671B1 (fr) | 2024-08-14 |
| AU2019311320A1 (en) | 2021-03-11 |
| CN112888456A (zh) | 2021-06-01 |
| CA3107080A1 (fr) | 2020-01-30 |
| FR3084086B1 (fr) | 2024-09-27 |
| BR112021001146A2 (pt) | 2021-04-20 |
| FR3084086A1 (fr) | 2020-01-24 |
| EP3826671C0 (fr) | 2024-08-14 |
| US11504424B2 (en) | 2022-11-22 |
| EP3826671A1 (fr) | 2021-06-02 |
| IL280335A (en) | 2021-03-25 |
| US20210283239A1 (en) | 2021-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265733B (en) | Methods and compositions for inducing protective immunity against human immunodeficiency virus infection | |
| ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
| EP3364983A4 (en) | VACCINES AGAINST RESPIRATORY VIRUS | |
| GB2592769B (en) | CpG-Adjuvanted SARS-CoV-2 virus vaccine | |
| SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
| ZA202004538B (en) | Influenza virus vaccines and uses thereof | |
| IL280335A (en) | A new attenuated virus strain and its use as a vaccine | |
| GB201910794D0 (en) | Vaccine | |
| HK1248536A1 (zh) | 疫苗組合物及其用途 | |
| EP3866847A4 (en) | ANTIVIRAL VACCINE | |
| EP3347044A4 (en) | BIRD FLUID VACCINE COMBINATION WITH VIRUS-RELATED PARTICLES AND NOVEL AUXILIARY SUBSTANCES | |
| IL259451B (en) | A live virus containing an attenuated dengue virus and a dengue vaccine containing identical antigens | |
| EP3102590A4 (en) | Antigenic epitopes from ebv gp350/220 and uses thereof | |
| ZA202104076B (en) | Hepatitis b virus vaccine and uses thereof | |
| GB201918196D0 (en) | HIV Vaccine | |
| AU2018903913A0 (en) | Virus Vaccine | |
| GB201818307D0 (en) | HIV Vaccine | |
| GB201818308D0 (en) | HIV Vaccine | |
| GB201911636D0 (en) | Vaccine | |
| GB201702193D0 (en) | Hepatitis E virus vaccine | |
| IL249704A0 (en) | Influenza virus vaccines and their uses | |
| IL249705A0 (en) | Influenza virus vaccines and their uses | |
| GB201707839D0 (en) | Attenuated virus | |
| AU2015904345A0 (en) | A filovirus vaccine and uses thereof | |
| AU2015901375A0 (en) | A vaccine composition and uses thereof |